BLATON M.D.: what changed
What changed
BLATON M.D.
filed annual accounts (NBB)
Net result for the year
-€398
2024 · -€750+€352
Equity
€11,697
2024 · €12,095-€398
Cash
€6,843
2024 · €6,843
Balance sheet total
€11,697
2024 · €12,095-€398
Largest movements
Assets
- Receivables within one year -€5,252
no longer reported in 2025 (was €5,252)
- Receivables after one year +€4,854
new in 2025: €4,854
Equity and liabilities
- Profit (loss) carried forward -€398
down €398 (-6.1%), from -€6,505 to -€6,903
Income statement
- Gross operating margin +€352
up €352 (+46.9%), from -€750 to -€398
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€750
Gross operating margin
+€352
Result 2025
-€398
raises the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
€0
Investment
€0
Financing
€0
Cash 2024
€6,843
From operations (derived)
€0
Net result for the year
-€398
Receivables after one year
-€4,854
Receivables within one year
+€5,252
Cash 2025
€6,843
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,095 | €11,697 | -€398 | -3.3% |
| Current assets | 29/58 | €12,095 | €11,697 | -€398 | -3.3% |
| Amounts receivable after more than one year | 29 | - | €4,854 | +€4,854 | |
| Other amounts receivable | 291 | - | €4,854 | +€4,854 | |
| Amounts receivable within one year | 40/41 | €5,252 | - | -€5,252 | |
| Other amounts receivable | 41 | €5,252 | - | -€5,252 | |
| Cash at bank and in hand | 54/58 | €6,843 | €6,843 | = | 0.0% |
| Total equity and liabilities | 10/49 | €12,095 | €11,697 | -€398 | -3.3% |
| Equity | 10/15 | €12,095 | €11,697 | -€398 | -3.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€6,505 | -€6,903 | -€398 | -6.1% |
| Gross operating margin | 9900 | -€750 | -€398 | +€352 | +46.9% |
| Operating profit (loss) | 9901 | -€750 | -€398 | +€352 | +46.9% |
| Profit (loss) for the period before taxes | 9903 | -€750 | -€398 | +€352 | +46.9% |
| Profit (loss) for the period | 9904 | -€750 | -€398 | +€352 | +46.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€750 | -€398 | +€352 | +46.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.